Expertise in
17
conditions

Dr. Morris D. Groves

Neurology
901 W 38th St Ste 200, 
Austin, TX 
Expertise in
17
conditions
901 W 38th St Ste 200, 
Austin, TX 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Morris Groves is a Neurologist in Austin, Texas. Dr. Groves is highly rated in 17 conditions, according to our data. His top areas of expertise are Brain Tumor, Glioma, Glioblastoma, and Astrocytoma.

His clinical research consists of co-authoring 45 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Institution
Baylor College Of Medicine
Specialties
Neurology
Licenses
Psychiatry & Neurology in TX
Languages Spoken
English
Gender
Male

Insurance

Please contact the provider to confirm they accept your insurance or if you don't see your insurance listed.

Accepted insurance plans

  •  Oscar
  •  Medicare

Locations

901 W 38th St Ste 200, Austin, TX 78705

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

An Open-Label, Multi-Center Trial of INO-5401 and INO-9012 Delivered by Electroporation (EP) in Combination With REGN2810 in Subjects With Newly-Diagnosed Glioblastoma (GBM)
An Open-Label, Multi-Center Trial of INO-5401 and INO-9012 Delivered by Electroporation (EP) in Combination With REGN2810 in Subjects With Newly-Diagnosed Glioblastoma (GBM)
Enrollment Status: Active_not_recruiting
Publish Date: March 21, 2025
Intervention Type: Biological, Drug, Radiation
Study Drugs: INO-5401, INO-9012, Cemiplimab, Temozolomide
Study Phase: Phase 1/Phase 2
Pivotal, Open-label, Randomized Study of Radiosurgery with or Without Tumor Treating Fields (TTFields) for 1-10 Brain Metastases from Non-small Cell Lung Cancer (NSCLC).
Pivotal, Open-label, Randomized Study of Radiosurgery with or Without Tumor Treating Fields (TTFields) for 1-10 Brain Metastases from Non-small Cell Lung Cancer (NSCLC).
Enrollment Status: Completed
Publish Date: January 28, 2025
Intervention Type: Device, Other
Study Phase: Phase 3
Two Phase I Studies in Patients With Brain Metastases From Any Primary Histology, Followed by a Randomized Phase 2 Study of RO4929097 Combined With CNS Radiotherapy in Patients With Brain Metastases From Breast Cancer Whose Tumors Are Estrogen Receptor Negative
Two Phase I Studies in Patients With Brain Metastases From Any Primary Histology, Followed by a Randomized Phase 2 Study of RO4929097 Combined With CNS Radiotherapy in Patients With Brain Metastases From Breast Cancer Whose Tumors Are Estrogen Receptor Negative
Enrollment Status: Terminated
Publish Date: November 19, 2024
Intervention Type: Other, Radiation, Procedure, Drug
Study Phase: Phase 1/Phase 2
A Phase 3 Randomized Double-blind, Controlled Study of ICT-107 With Maintenance Temozolomide (TMZ) in Newly Diagnosed Glioblastoma Following Resection and Concomitant TMZ Chemoradiotherapy
A Phase 3 Randomized Double-blind, Controlled Study of ICT-107 With Maintenance Temozolomide (TMZ) in Newly Diagnosed Glioblastoma Following Resection and Concomitant TMZ Chemoradiotherapy
Enrollment Status: Suspended
Publish Date: April 03, 2024
Intervention Type: Biological
Study Phase: Phase 3
A Phase II, Multi-center, Open-label Study of a Conditionally Replicative Adenovirus (DNX-2401) With Pembrolizumab (KEYTRUDA®) for Recurrent Glioblastoma or Gliosarcoma (CAPTIVE/KEYNOTE-192)
A Phase II, Multi-center, Open-label Study of a Conditionally Replicative Adenovirus (DNX-2401) With Pembrolizumab (KEYTRUDA®) for Recurrent Glioblastoma or Gliosarcoma (CAPTIVE/KEYNOTE-192)
Enrollment Status: Completed
Publish Date: July 15, 2021
Intervention Type: Biological
Study Drugs: DNX-2401 Adeno-Associated Oncolytic Virus Delta-24 Vaccine, Pembrolizumab
Study Phase: Phase 2
A Phase 3, Randomized, Controlled, Double-Arm, Open-Label, Multi-center Study of VB-111 Combined With Bevacizumab vs. Bevacizumab Monotherapy in Patients With Recurrent Glioblastoma
A Phase 3, Randomized, Controlled, Double-Arm, Open-Label, Multi-center Study of VB-111 Combined With Bevacizumab vs. Bevacizumab Monotherapy in Patients With Recurrent Glioblastoma
Enrollment Status: Completed
Publish Date: October 23, 2018
Intervention Type: Drug
Study Phase: Phase 3
View 5 Less Clinical Trials

45 Total Publications

Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial.
Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial.
Journal: Nature medicine
Published: August 20, 2022
Similar Doctors
Expertise in
19
conditions
Dr. Michael J. Soileau
Neurology
Expertise in
19
conditions
Dr. Michael J. Soileau
Neurology

Legacy Healthcare Services Inc

3405 El Salido Pkwy, 
Cedar Park, TX 
 (11.8 mi)
512-243-6556
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Michael Soileau is a Neurologist in Cedar Park, Texas. Dr. Soileau is highly rated in 19 conditions, according to our data. His top areas of expertise are Parkinson's Disease, Movement Disorders, Essential Tremor, Deep Brain Stimulation, and Gastrostomy. Dr. Soileau is currently accepting new patients.

Expertise in
10
conditions
Dr. Sami M. Aboumatar
Neurology
Expertise in
10
conditions
Dr. Sami M. Aboumatar
Neurology
2200 Park Bend Dr, Bldg 2 203, 
Austin, TX 
 (7.6 mi)
512-339-8831
Languages Spoken:
English, Arabic, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Sami Aboumatar is a Neurologist in Austin, Texas. Dr. Aboumatar is highly rated in 10 conditions, according to our data. Their top areas of expertise are Seizures, Memory Loss, Generalized Tonic-Clonic Seizure, and Status Epilepticus. Dr. Aboumatar is currently accepting new patients.

Expertise in
6
conditions
Dr. Edward J. Fox
Neurology
Expertise in
6
conditions
Dr. Edward J. Fox
Neurology
16040 Park Valley Dr, Building B, Suite 100, 
Round Rock, TX 
 (14.5 mi)
512-218-1222
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Edward Fox is a Neurologist in Round Rock, Texas. Dr. Fox is highly rated in 6 conditions, according to our data. His top areas of expertise are Relapsing Multiple Sclerosis (RMS), Multiple Sclerosis (MS), Neuromyelitis Optica, Osteotomy, and Nerve Decompression. Dr. Fox is currently accepting new patients.

Areas of Expertise

When evaluating expertise, MediFind pulls from factors such as the number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

To learn more about how MediFind determines the expertise levels, check out our expert tiers page.

Find Dr. Groves's expertise for a condition
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile